Resistance of beta-endorphin to dexamethasone inhibition in parkinson's and alzheimer's diseases

L. Airaghi, A. Catania, C. Gramigna, M. G. Manfredi, M. Franceschi, C. Zanussi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The response of plasma beta-endorphin (beta-EP) to dexamethasone suppression was studied in 14 patients with Alzheimer's disease (AD), 14 patients with Parkinson's disease (PD), and 13 age-matched controls in order to evaluate whether an impairment of the opiate system is present in these neurodegenerative disorders. Basal circulating beta-EP was in normal range in all subjects, although the mean concentration was slightly reduced in the patients compared to controls. After 1 mg dexamethasone given at 11:00p.m. the night before, plasma beta-EP concentration measured at 08:00 a.m. and 04:00 p.m. was not inhibited in AD and PD patients while it was significantly reduced in controls. Circulating ACTH and Cortisol were similar in patients and controls and a normal inhibition of plasma Cortisol after dexamethasone was observed in 13/14 AD and 12/14PD patients. The resistance of beta-EP to dexamethasone inhibition is consistent with previous clinical and experimental data indicating a disorder of the opiate system in brain degenerative diseases.

Original languageEnglish
Pages (from-to)73-79
Number of pages7
JournalInternational Journal of Neuroscience
Volume56
Issue number1-4
DOIs
Publication statusPublished - 1991

Fingerprint

beta-Endorphin
Dexamethasone
Parkinson Disease
Alzheimer Disease
Opiate Alkaloids
Hydrocortisone
Brain Diseases
Neurodegenerative Diseases
Adrenocorticotropic Hormone
Inhibition (Psychology)
Reference Values

Keywords

  • Alzheimer's disease
  • Beta-endorphin
  • Dexamethasone suppression
  • Parkinson's diseases

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Resistance of beta-endorphin to dexamethasone inhibition in parkinson's and alzheimer's diseases. / Airaghi, L.; Catania, A.; Gramigna, C.; Manfredi, M. G.; Franceschi, M.; Zanussi, C.

In: International Journal of Neuroscience, Vol. 56, No. 1-4, 1991, p. 73-79.

Research output: Contribution to journalArticle

Airaghi, L. ; Catania, A. ; Gramigna, C. ; Manfredi, M. G. ; Franceschi, M. ; Zanussi, C. / Resistance of beta-endorphin to dexamethasone inhibition in parkinson's and alzheimer's diseases. In: International Journal of Neuroscience. 1991 ; Vol. 56, No. 1-4. pp. 73-79.
@article{d97951bd2e8a4890ad8b2e12c58619d1,
title = "Resistance of beta-endorphin to dexamethasone inhibition in parkinson's and alzheimer's diseases",
abstract = "The response of plasma beta-endorphin (beta-EP) to dexamethasone suppression was studied in 14 patients with Alzheimer's disease (AD), 14 patients with Parkinson's disease (PD), and 13 age-matched controls in order to evaluate whether an impairment of the opiate system is present in these neurodegenerative disorders. Basal circulating beta-EP was in normal range in all subjects, although the mean concentration was slightly reduced in the patients compared to controls. After 1 mg dexamethasone given at 11:00p.m. the night before, plasma beta-EP concentration measured at 08:00 a.m. and 04:00 p.m. was not inhibited in AD and PD patients while it was significantly reduced in controls. Circulating ACTH and Cortisol were similar in patients and controls and a normal inhibition of plasma Cortisol after dexamethasone was observed in 13/14 AD and 12/14PD patients. The resistance of beta-EP to dexamethasone inhibition is consistent with previous clinical and experimental data indicating a disorder of the opiate system in brain degenerative diseases.",
keywords = "Alzheimer's disease, Beta-endorphin, Dexamethasone suppression, Parkinson's diseases",
author = "L. Airaghi and A. Catania and C. Gramigna and Manfredi, {M. G.} and M. Franceschi and C. Zanussi",
year = "1991",
doi = "10.3109/00207459108985406",
language = "English",
volume = "56",
pages = "73--79",
journal = "International Journal of Neuroscience",
issn = "0020-7454",
publisher = "Informa Healthcare",
number = "1-4",

}

TY - JOUR

T1 - Resistance of beta-endorphin to dexamethasone inhibition in parkinson's and alzheimer's diseases

AU - Airaghi, L.

AU - Catania, A.

AU - Gramigna, C.

AU - Manfredi, M. G.

AU - Franceschi, M.

AU - Zanussi, C.

PY - 1991

Y1 - 1991

N2 - The response of plasma beta-endorphin (beta-EP) to dexamethasone suppression was studied in 14 patients with Alzheimer's disease (AD), 14 patients with Parkinson's disease (PD), and 13 age-matched controls in order to evaluate whether an impairment of the opiate system is present in these neurodegenerative disorders. Basal circulating beta-EP was in normal range in all subjects, although the mean concentration was slightly reduced in the patients compared to controls. After 1 mg dexamethasone given at 11:00p.m. the night before, plasma beta-EP concentration measured at 08:00 a.m. and 04:00 p.m. was not inhibited in AD and PD patients while it was significantly reduced in controls. Circulating ACTH and Cortisol were similar in patients and controls and a normal inhibition of plasma Cortisol after dexamethasone was observed in 13/14 AD and 12/14PD patients. The resistance of beta-EP to dexamethasone inhibition is consistent with previous clinical and experimental data indicating a disorder of the opiate system in brain degenerative diseases.

AB - The response of plasma beta-endorphin (beta-EP) to dexamethasone suppression was studied in 14 patients with Alzheimer's disease (AD), 14 patients with Parkinson's disease (PD), and 13 age-matched controls in order to evaluate whether an impairment of the opiate system is present in these neurodegenerative disorders. Basal circulating beta-EP was in normal range in all subjects, although the mean concentration was slightly reduced in the patients compared to controls. After 1 mg dexamethasone given at 11:00p.m. the night before, plasma beta-EP concentration measured at 08:00 a.m. and 04:00 p.m. was not inhibited in AD and PD patients while it was significantly reduced in controls. Circulating ACTH and Cortisol were similar in patients and controls and a normal inhibition of plasma Cortisol after dexamethasone was observed in 13/14 AD and 12/14PD patients. The resistance of beta-EP to dexamethasone inhibition is consistent with previous clinical and experimental data indicating a disorder of the opiate system in brain degenerative diseases.

KW - Alzheimer's disease

KW - Beta-endorphin

KW - Dexamethasone suppression

KW - Parkinson's diseases

UR - http://www.scopus.com/inward/record.url?scp=0025987522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025987522&partnerID=8YFLogxK

U2 - 10.3109/00207459108985406

DO - 10.3109/00207459108985406

M3 - Article

VL - 56

SP - 73

EP - 79

JO - International Journal of Neuroscience

JF - International Journal of Neuroscience

SN - 0020-7454

IS - 1-4

ER -